Current strategies for the prevention of breast cancer

References

• HowladerNNooneAMKrapchoMSEER Cancer Statistics Review (CSR), 1975–2010 [webpage on the Internet]Bethesda, MDNational Cancer Institute2013 [updated June 14, 2013]. Available from: http://seer.cancer.gov/csr/1975_2010/Accessed January 6, 2014
   Google Scholar
• Cancer Facts and Figures 2013Atlanta, GAAmerican Cancer Society2013 Available from: http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013Accessed November, 2013
   Google Scholar
• Breast Cancer Facts and Figures 2013–2014Atlanta, GAAmerican Cancer Society, Inc.2013 Available from: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-040951.pdfAccessed January 6, 2014
   Google Scholar
• CopelandGLakeAFirthRCancer in North America: 2006–2010. Volume One: Combined Cancer Incidence for the United States, Canada, and North AmericaSpringfield, ILNorth American Association of Central Cancer Registries, Inc.2013 Available from: http://www.naaccr.org/LinkClick.aspx?fileticket=saVl1AbSyFA%3D&tabid=93&mid=433Accessed January 6, 2014
   Google Scholar
• FaschingPAEkiciABAdamietzBRBreast cancer risk – genes, environment and clinicsGeburtshilfe Frauenheilkd20117110561066
   PubMed Web of Science ®Google Scholar
• MahoneyMCBeversTLinosEWillettWCOpportunities and strategies for breast cancer prevention through risk reductionCA Cancer J Clin200858634737118981297
   PubMed Web of Science ®Google Scholar
• BarlowWEWhiteEBallard-BarbashRProspective breast cancer risk prediction model for women undergoing screening mammographyJ Natl Cancer Inst200698171204121416954473
   PubMed Web of Science ®Google Scholar
• BoydNFGuoHMartinLJMammographic density and the risk and detection of breast cancerN Engl J Med2007356322723617229950
   PubMed Web of Science ®Google Scholar
• McCormackVAdos Santos SilvaIBreast density and parenchymal patterns as markers of breast cancer risk: a meta-analysisCancer Epidemiol Biomarkers Prev20061561159116916775176
   PubMed Web of Science ®Google Scholar
• TiceJACummingsSRSmith-BindmanRIchikawaLBarlowWEKerlikowskeKUsing clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive modelAnn Intern Med2008148533734718316752
   PubMed Web of Science ®Google Scholar
• TiceJACummingsSRZivEKerlikowskeKMammographic breast density and the Gail model for breast cancer risk prediction in a screening populationBreast Cancer Res Treat200594211512216261410
   PubMed Web of Science ®Google Scholar
• WarnerELockwoodGTritchlerDBoydNFThe risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classificationCancer Detect Prev199216167721532349
   PubMedGoogle Scholar
• PetterssonAHankinsonSEWillettWCLagiouPTrichopoulosDTamimiRMNondense mammographic area and risk of breast cancerBreast Cancer Res2011135R10022017857
   PubMed Web of Science ®Google Scholar
• RauhCHackCCHaberleLPercent mammographic density and dense area as risk factors for breast cancerGeburtshilfe Frauenheilkd201272727733
   Web of Science ®Google Scholar
• TravisLBHillDDoresGMCumulative absolute breast cancer risk for young women treated for Hodgkin lymphomaJ Natl Cancer Inst200597191428143716204692
   PubMedGoogle Scholar
• ClausEBRischNThompsonWDGenetic analysis of breast cancer in the cancer and steroid hormone studyAm J Human Genet19914822322421990835
   PubMed Web of Science ®Google Scholar
• GailMHBrintonLAByarDPProjecting individualized probabilities of developing breast cancer for white females who are being examined annuallyJ Natl Cancer Inst19898124187918862593165
   PubMed Web of Science ®Google Scholar
• GailMHCostantinoJPPeeDProjecting individualized absolute invasive breast cancer risk in African American womenJ Natl Cancer Inst200799231782179218042936
   PubMed Web of Science ®Google Scholar
• MatsunoRKCostantinoJPZieglerRGProjecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American womenJ Natl Cancer Inst20111031295196121562243
   PubMedGoogle Scholar
• ClausEBRischNThompsonWDThe calculation of breast cancer risk for women with a first degree family history of ovarian cancerBreast Cancer Res Treat19932821151208173064
   PubMed Web of Science ®Google Scholar
• ParmigianiGBerryDAguilarODetermining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2Am J Human Genet19986211451589443863
   PubMed Web of Science ®Google Scholar
• TyrerJDuffySWCuzickJA breast cancer prediction model incorporating familial and personal risk factorsStat Med20042371111113015057881
   PubMed Web of Science ®Google Scholar
• GabrielEMJatoiIBreast cancer chemopreventionExpert Rev Anticancer Ther201212222322822316370
   PubMed Web of Science ®Google Scholar
• HongWKSpornMBRecent advances in chemoprevention of cancerScience19972785340107310779353183
   PubMed Web of Science ®Google Scholar
• FisherBCostantinoJPWickerhamDLTamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJ Natl Cancer Inst19989018137113889747868
   PubMed Web of Science ®Google Scholar
• FisherBCostantinoJPWickerhamDLTamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 studyJ Natl Cancer Inst200597221652166216288118
   PubMed Web of Science ®Google Scholar
• VeronesiUMaisonneuvePCostaAPrevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention StudyLancet1998352912293979672273
   PubMed Web of Science ®Google Scholar
• VeronesiUMaisonneuvePRotmenszNItalian Tamoxifen Study GroupTamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomyJ Natl Cancer Inst200799972773717470740
   PubMedGoogle Scholar
• PowlesTEelesRAshleySInterim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialLancet19983529122981019672274
   PubMed Web of Science ®Google Scholar
• PowlesTJAshleySTidyASmithIEDowsettMTwenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trialJ Natl Cancer Inst200799428329017312305
   PubMedGoogle Scholar
• CuzickJForbesJEdwardsRIBIS investigatorsFirst results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trialLancet2002360933681782412243915
   PubMed Web of Science ®Google Scholar
• CuzickJForbesJFSestakIInternational Breast Cancer Intervention Study I InvestigatorsLong-term results of tamoxifen prophylaxis for breast cancer – 96-month follow-up of the randomized IBIS-I trialJ Natl Cancer Inst200799427228217312304
   PubMed Web of Science ®Google Scholar
• CuzickJPowlesTVeronesiUOverview of the main outcomes in breast-cancer prevention trialsLancet2003361935429630012559863
   PubMed Web of Science ®Google Scholar
• AtkinsonCWarrenRBinghamSADayNEMammographic patterns as a predictive biomarker of breast cancer risk: effect of tamoxifenCancer Epidemiol Biomarkers Prev199981086386610548313
   PubMed Web of Science ®Google Scholar
• BrissonJBrissonBCotéGMaunsellEBérubéSRobertJTamoxifen and mammographic breast densitiesCancer Epidemiol Biomarkers Prev20009991191511008908
   PubMed Web of Science ®Google Scholar
• CuzickJWarwickJPinneyEWarrenRMDuffySWTamoxifen and breast density in women at increased risk of breast cancerJ Natl Cancer Inst200496862162815100340
   PubMedGoogle Scholar
• CuzickJWarwickJPinneyETamoxifen-induced reduction in mammographic density and breast cancer risk reduction: a nested case-control studyJ Natl Cancer Inst2011103974475221483019
   PubMedGoogle Scholar
• Raloxifene [package insert]USAEli Lilly and Company2007
   Google Scholar
• EttingerBBlackDMMitlakBHReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsJAMA1999282763764510517716
   PubMed Web of Science ®Google Scholar
• CauleyJANortonLLippmanMEContinued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluationBreast Cancer Res Treat200165212513411261828
   PubMed Web of Science ®Google Scholar
• CummingsSREckertSKruegerKAThe effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene EvaluationJAMA1999281232189219710376571
   PubMed Web of Science ®Google Scholar
• MartinoSCauleyJABarrett-ConnorECORE InvestigatorsContinuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifeneJ Natl Cancer Inst200496231751176115572757
   PubMedGoogle Scholar
• VogelVGCostantinoJPWickerhamDLNational Surgical Adjuvant Breast and Bowel Project (NSABP)Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialJAMA2006295232727274116754727
   PubMed Web of Science ®Google Scholar
• LandSRWickerhamDLCostantinoJPPatient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialJAMA2006295232742275116754728
   PubMed Web of Science ®Google Scholar
• VogelVGCostantinoJPWickerhamDLNational Surgical Adjuvant Breast and Bowel ProjectUpdate of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: preventing breast cancerCancer Prev Res (Phila)20103669670620404000
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEMoscaLCollinsPRaloxifene Use for The Heart (RUTH) Trial InvestigatorsEffects of raloxifene on cardiovascular events and breast cancer in postmenopausal womenN Engl J Med2006355212513716837676
   PubMed Web of Science ®Google Scholar
• CummingsSREnsrudKDelmasPDPEARL Study InvestigatorsLasofoxifene in postmenopausal women with osteoporosisN Engl J Med2010362868669620181970
   PubMed Web of Science ®Google Scholar
• LaCroixAZPowlesTOsborneCKPEARL InvestigatorsBreast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic womenJ Natl Cancer Inst2010102221706171521051656
   PubMedGoogle Scholar
• CummingsSRMcClungMReginsterJYArzoxifene for prevention of fractures and invasive breast cancer in postmenopausal womenJ Bone Miner Res201126239740420658564
   PubMed Web of Science ®Google Scholar
• PowlesTJDiemSJFabianCJBreast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifeneBreast Cancer Res Treat2012134129930622484799
   PubMed Web of Science ®Google Scholar
• GossPEStrasserKAromatase inhibitors in the treatment and prevention of breast cancerJ Clin Oncol200119388189411157042
   PubMed Web of Science ®Google Scholar
• BaumMBudzarAUCuzickJAnastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialLancet200235993242131213912090977
   PubMed Web of Science ®Google Scholar
• CoombesRCHallEGibsonLJIntergroup Exemestane StudyA randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancerN Engl J Med2004350111081109215014181
   PubMed Web of Science ®Google Scholar
• GossPEIngleJNMartinoSA randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancerN Engl J Med2003349191793180214551341
   PubMed Web of Science ®Google Scholar
• GossPEIngleJNAlés-Martínez JE, et al; NCIC CTG MAP.3 Study Investigators. Exemestane for breast-cancer prevention in postmenopausal womenN Engl J Med2011364252381239121639806
   PubMed Web of Science ®Google Scholar
• CuzickJSestakIForbesJFon behalf of the IBIS-II investigatorsAnastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialLancet Epub12122013
   Web of Science ®Google Scholar
• CuzickJSestakIBonanniBSERM Chemoprevention of Breast Cancer Overview GroupSelective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant dataLancet201338198801827183423639488
   PubMed Web of Science ®Google Scholar
• BosettiCRosatoVGallusSCuzickJLa VecchiaCAspirin and cancer risk: a quantitative review to 2011Ann Oncol20122361403141522517822
   PubMed Web of Science ®Google Scholar
• TakkoucheBRegueira-MendezCEtminanMBreast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysisJ Natl Cancer Inst2008100201439144718840819
   PubMedGoogle Scholar
• CookNRLeeIMGazianoJMLow-dose aspirin in the primary prevention of cancer: the Women’s Health Study: a randomized controlled trialJAMA20052941475515998890
   PubMed Web of Science ®Google Scholar
• ZhangXSmith-WarnerSACollinsLCRosnerBWillettWCHankinsonSEUse of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidenceJ Clin Oncol201230283468347722927520
   PubMed Web of Science ®Google Scholar
• HolmesMDChenWYLiLHertzmarkESpiegelmanDHankinsonSEAspirin intake and survival after breast cancerJ Clin Oncol20102891467147220159825
   PubMed Web of Science ®Google Scholar
• GunterMJHooverDRYuHInsulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal womenJ Natl Cancer Inst20091011486019116382
   PubMedGoogle Scholar
• ColNFOchsLSpringmannVAragakiAKChlebowskiRTMetformin and breast cancer risk: a meta-analysis and critical literature reviewBreast Cancer Res Treat2012135363964622847511
   PubMed Web of Science ®Google Scholar
• ChlebowskiRTMcTiernanAWactawski-WendeJDiabetes, metformin, and breast cancer in postmenopausal womenJ Clin Oncol201230232844285222689798
   PubMed Web of Science ®Google Scholar
• NelsonERWardellSEJasperJS27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiologyScience201334261621094109824288332
   PubMed Web of Science ®Google Scholar
• VisvanathanKHurleyPBantugEUse of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guidelineJ Clin Oncol201331232942296223835710
   PubMed Web of Science ®Google Scholar
• KingMCWieandSHaleKNational Surgical Adjuvant Breast and Bowel ProjectTamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention TrialJAMA2001286182251225611710890
   PubMed Web of Science ®Google Scholar
• World Cancer Research Fund/American Institute for Cancer ResearchFood, Nutrition, Physical Activity, and the Prevention of Cancer: a Global PerspectiveWashington DCAICR2007
   Google Scholar
• HamajimaNHiroseKTajimaKCollaborative Group on Hormonal Factors in Breast CancerAlcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the diseaseBr J Cancer200287111234124512439712
   PubMed Web of Science ®Google Scholar
• Smith-WarnerSASpiegelmanDYaunSSAlcohol and breast cancer in women: a pooled analysis of cohort studiesJAMA199827975355409480365
   PubMed Web of Science ®Google Scholar
• LarssonSCGiovannucciEWolkAFolate and risk of breast cancer: a meta-analysisJ Natl Cancer Inst2007991647617202114
   PubMedGoogle Scholar
• ZhangSMLeeIMMansonJECookNRWillettWCBuringJEAlcohol consumption and breast cancer risk in the Women’s Health StudyAm J Epidemiol2007165666767617204515
   PubMed Web of Science ®Google Scholar
• ZhangSMWillettWCSelhubJPlasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancerJ Natl Cancer Inst200395537338012618502
   PubMedGoogle Scholar
• BoydNFStoneJVogtKNConnellyBSMartinLJMinkinSDietary fat and breast cancer risk revisited: a meta-analysis of the published literatureBr J Cancer20038991672168514583769
   PubMed Web of Science ®Google Scholar
• PrenticeRLCaanBChlebowskiRTLow-fat dietary pattern and risk of invasive breast cancer: the Women’s Health Initiative Randomized Controlled Dietary Modification TrialJ Am Med Assoc20062956629642
   PubMed Web of Science ®Google Scholar
• MissmerSASmith-WarnerSASpiegelmanDMeat and dairy food consumption and breast cancer: a pooled analysis of cohort studiesInt J Epidemiol2002311788511914299
   PubMed Web of Science ®Google Scholar
• TaylorEFBurleyVJGreenwoodDCCadeJEMeat consumption and risk of breast cancer in the UK Women’s Cohort StudyBr J Cancer20079671139114617406351
   PubMed Web of Science ®Google Scholar
• WillettWCNurses’ HealthStudyII(NHS II): risk factors for breast cancer among younger nurses [webpage on the Internet]Bethesda, MDNational Cancer Institute [updated March 22, 2013]. Available from: http://epi.grants.cancer.gov/Consortia/members/nhs2.htmlAccessed December 2013
   Google Scholar
• FoulkesWDInherited susceptibility to common cancersN Engl J Med2008359202143215319005198
   PubMed Web of Science ®Google Scholar
• PharoahPDAntoniouABobrowMZimmernRLEastonDFPonderBAPolygenic susceptibility to breast cancer and implications for preventionNat Genet2002311333611984562
   PubMed Web of Science ®Google Scholar
• WeischerMBojesenSETybjaerg-HansenAAxelssonCKNordestgaardBGIncreased risk of breast cancer associated with CHEK2*1100delCJ Clin Oncol2007251576316880452
   PubMed Web of Science ®Google Scholar
• NCCN Guidelines^®[webpage on the Internet]Fort Washington, PANational Comprehensive Cancer Network Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#genetics_screeningAccessed December 2013
   Google Scholar
• SaslowDBoetesCBurkeWAmerican Cancer Society Breast Cancer Advisory GroupAmerican Cancer Society guidelines for breast screening with MRI as an adjunct to mammographyCA Cancer J Clin2007572758917392385
   PubMed Web of Science ®Google Scholar
• HartmannLCSchaidDJWoodsJEEfficacy of bilateral prophylactic mastectomy in women with a family history of breast cancerN Engl J Med1999340277849887158
   PubMed Web of Science ®Google Scholar
• HartmannLCSellersTASchaidDJEfficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriersJ Natl Cancer Inst200193211633163711698567
   PubMedGoogle Scholar
• Meijers-HeijboerHvan GeelBvan PuttenWLBreast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutationN Engl J Med2001345315916411463009
   PubMed Web of Science ®Google Scholar
• RebbeckTRFriebelTLynchHTBilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study GroupJ Clin Oncol20042261055106214981104
   PubMed Web of Science ®Google Scholar
• EisenALubinskiJKlijnJBreast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control studyJ Clin Oncol200523307491749616234515
   PubMed Web of Science ®Google Scholar
• RebbeckTRKauffNDDomchekSMMeta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriersJ Natl Cancer Inst20091012808719141781
   PubMedGoogle Scholar
• RebbeckTRLevinAMEisenABreast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriersJ Natl Cancer Inst199991171475147910469748
   PubMed Web of Science ®Google Scholar
• RebbeckTRLynchHTNeuhausenSLPrevention and Observation of Surgical End Points Study GroupProphylactic oophorectomy in carriers of BRCA1 or BRCA2 mutationsN Engl J Med2002346211616162212023993
   PubMed Web of Science ®Google Scholar
• KauffNDDomchekSMFriebelTMRisk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective studyJ Clin Oncol20082681331133718268356
   PubMed Web of Science ®Google Scholar
• KinsingerLSHarrisRWoolfSHSoxHCLohrKNChemoprevention of breast cancer: a summary of the evidence for the US Preventive Services Task ForceAnn Intern Med20021371596912093250
   PubMed Web of Science ®Google Scholar
• FreedmanANGraubardBIRaoSRMcCaskill-StevensWBallard-BarbashRGailMHEstimates of the number of US women who could benefit from tamoxifen for breast cancer chemopreventionJ Natl Cancer Inst200395752653212671020
   PubMedGoogle Scholar
• TaylorFHuffmanMDMacedoAFStatins for the primary prevention of cardiovascular diseaseCochrane Database Syst Rev20131CD00481623440795
   PubMed Web of Science ®Google Scholar
• WatersEACroninKAGraubardBIHanPKFreedmanANPrevalence of tamoxifen use for breast cancer chemoprevention among US womenCancer Epidemiol Biomarkers Prev201019244344620142242
   PubMed Web of Science ®Google Scholar
• Breast Screening Available from: http://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdfFort Washington, PANational Comprehensive Cancer Network2014Accessed January 6, 2014
   Google Scholar
• FreedmanANYuBGailMHBenefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or olderJ Clin Oncol201129172327233321537036
   PubMed Web of Science ®Google Scholar
• Stanford UniversityPhase II Trial - Breast Cancer Chemoprevention by Lovastatin Available from: http://clinicaltrials.gov/show/NCT00285857. NLM identifier: NCT00285857Accessed January 21, 2014
   Google Scholar
• National Cancer Institute (NCI)A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer Available from: http://clinicaltrials.gov/show/NCT00637481. NLM identifier: NCT00637481Accessed January 21, 2014
   Google Scholar
• UNICANCERLetrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation (LIBER) Available from: http://clinicaltrials.gov/show/NCT00673335. NLM identifier: NCT00673335Accessed January 21, 2014
   Google Scholar
• KatherineDCrew. Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer Available from: http://clinicaltrials.gov/show/NCT00976339. NLM identifier: NCT00976339Accessed January 21, 2014
   Google Scholar
• New York University School of MedicineBreast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial Available from: http://clinicaltrials.gov/show/NCT01372644. NLM identifier: NCT01372644Accessed January 21, 2014
   Google Scholar